Related Experiment Video
Updated: Mar 14, 2026
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional
Tamara D Simon1, Matthew P Kronman1, Kathryn B Whitlock2
1Department of Pediatrics, University of Washington/Seattle Children's Hospital, Seattle, WA; Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA.
Insights
Treatment for cerebrospinal fluid (CSF) shunt infections in children often involves surgical intervention and intravenous antibiotics. While surgical approaches align with guidelines, antibiotic durations frequently exceed recommendations.
Area of Science:
- Pediatric Neurosurgery
- Infectious Diseases
- Clinical Research
Background:
- Cerebrospinal fluid (CSF) shunt infections are a significant complication in pediatric hydrocephalus management.
- Current Infectious Diseases Society of America (IDSA) guidelines provide recommendations for treatment, but adherence and outcomes vary.
- Understanding treatment variations is crucial for optimizing patient care and outcomes.
Purpose of the Study:
- To evaluate surgical and antibiotic treatment strategies for initial CSF shunt infections in children.
- To assess adherence to IDSA guidelines in the management of these infections.
- To describe variations in treatment approaches and their duration.
Main Methods:
- Prospective cohort study involving 151 children treated for first CSF shunt infection.
- Data collected from 7 Hydrocephalus Clinical Research Network hospitals (April 2008-December 2012).
- Univariate analyses used to describe the study population and treatment patterns.
Main Results:
- Most children (65%) had initial shunt placement before 6 months of age, with median infection time of 28 days post-surgery.
- Surgical management typically involved shunt removal, external ventricular drain placement, and new shunt insertion (81%).
- Median intravenous antibiotic duration was 19 days; 73% of cases exceeded IDSA guideline recommendations.
Conclusions:
- Surgical management for CSF shunt infections generally follows IDSA guidelines.
- The duration of intravenous antibiotic therapy for CSF shunt infections consistently exceeds IDSA recommendations.
- Further research may be needed to refine antibiotic duration guidelines for pediatric CSF shunt infections.
Objectives:
To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines.
Study Design:
We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population.
Results:
A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n = 98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended.
Conclusions:
Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.
Related Concept Videos
01:22Aneurysm IV: Nursing Management
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:17Urinary Tract Infection IV: Nursing Management
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: